Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Exp Neurol ; 229(2): 391-8, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21419118

ABSTRACT

Ischemic stroke induces migration of newly formed neuroblasts, generated by neural stem cells in the adult rat subventricular zone (SVZ), towards the injured striatum where they differentiate into mature neurons. Stroke also leads to accumulation of microglia in the SVZ but their role for neurogenesis is unclear. Here we developed a method for selective depletion of the macrophage antigen complex-1 (Mac-1)-expressing microglia population in the SVZ by intraventricular injection of the immunotoxin Mac-1-saporin in rats. We found that the vast majority of Mac-1+ cells were Iba-1+ microglia. The Mac-1+ population was heterogeneous and included both a small proliferative pool of cells, which was not affected by middle cerebral artery occlusion (MCAO), and a larger subpopulation that changed morphologically into a semi-activated state in response to the insult. This subpopulation did not increase its expression of the phagocytic marker ED1 but exhibited high levels of triggering receptor expressed on myeloid cells-2 (TREM-2), associated with alternative microglia activation. A minor portion of the SVZ Mac-1+ cells originated from the blood early after stroke, but this macrophage population became much more substantial at later stages. Almost 80% reduction of Mac-1-expressing microglia, caused by Mac-1 saporin delivered just before and at 1 week after MCAO, did not alter the numbers of newly formed neuroblasts in the striatum or their migratory distance. These findings indicate that the Mac-1-expressing microglia in the SVZ do not play a major role either for the number of neuroblasts which exit the SVZ or their migration in the striatum early following stroke.


Subject(s)
Brain Ischemia/metabolism , Lateral Ventricles/metabolism , Macrophage-1 Antigen/metabolism , Microglia/metabolism , Neurogenesis/physiology , Neurons/metabolism , Stroke/metabolism , Analysis of Variance , Animals , Brain Ischemia/physiopathology , Fluorescent Antibody Technique , Immunohistochemistry , Lateral Ventricles/cytology , Lateral Ventricles/physiopathology , Male , Microscopy, Confocal , Neurons/cytology , Rats , Rats, Wistar , Stroke/physiopathology
2.
Glia ; 57(8): 835-49, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19053043

ABSTRACT

Neural stem cells (NSCs) in the adult rat subventricular zone (SVZ) generate new striatal neurons during several months after ischemic stroke. Whether the microglial response associated with ischemic injury extends into SVZ and influences neuroblast production is unknown. Here, we demonstrate increased numbers of activated microglia in ipsilateral SVZ concomitant with neuroblast migration into the striatum at 2, 6, and 16 weeks, with maximum at 6 weeks, following 2 h middle cerebral artery occlusion in rats. In the peri-infarct striatum, numbers of activated microglia peaked already at 2 weeks and declined thereafter. Microglia in SVZ were resident or originated from bone marrow, with maximum proliferation during the first 2 weeks postinsult. In SVZ, microglia exhibited ramified or intermediate morphology, signifying a downregulated inflammatory profile, whereas amoeboid or round phagocytic microglia were frequent in the peri-infarct striatum. Numbers of microglia expressing markers of antigen-presenting cells (MHC-II, CD86) increased in SVZ but very few lymphocytes were detected. Using quantitative PCR, strong short- and long-term increase (at 1 and 6 weeks postinfarct) of insulin-like growth factor-1 (IGF-1) gene expression was detected in SVZ tissue. Elevated numbers of IGF-1-expressing microglia were found in SVZ at 2, 6, and 16 weeks after stroke. At 16 weeks, 5% of microglia but no other cells in SVZ expressed the IGF-1 protein, which mitigates apoptosis and promotes proliferation and differentiation of NSCs. The long-term accumulation of microglia with proneurogenic phenotype in the SVZ implies a supportive role of these cells for the continuous neurogenesis after stroke.


Subject(s)
Lateral Ventricles/physiopathology , Microglia/physiology , Neurogenesis/physiology , Stroke/pathology , Stroke/surgery , Analysis of Variance , Animals , Antigen-Presenting Cells/metabolism , Bone Marrow Transplantation/methods , Calcium-Binding Proteins/genetics , Calcium-Binding Proteins/metabolism , Cell Movement/physiology , Cell Proliferation/radiation effects , Corpus Striatum/physiopathology , Disease Models, Animal , Ectodysplasins/genetics , Ectodysplasins/metabolism , Functional Laterality , Green Fluorescent Proteins/genetics , Insulin-Like Growth Factor I/genetics , Insulin-Like Growth Factor I/metabolism , Leukocyte Common Antigens/genetics , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microfilament Proteins , Microglia/metabolism , Phenotype , Rats , Rats, Wistar , Stroke/physiopathology , Time Factors
3.
Exp Neurol ; 196(1): 204-8, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16157335

ABSTRACT

Stroke induced by 2 h middle cerebral artery occlusion triggers increased striatal and hippocampal neurogenesis in adult rats. We investigated the effect of tumor necrosis factor-alpha (TNF-alpha) inhibition on the survival of the new neurons. The mitotic marker BrdU was given on days 5 to 7, and TNF-alpha antibody or control protein was infused into the lateral ventricle of the ischemic hemisphere from day 8 to 14 after stroke. At the end of infusions, the TNF-alpha antibody-treated rats showed markedly fewer new striatal and hippocampal neurons, as compared to animals given control protein. The present findings suggest that TNF-alpha, probably acting via its receptor TNFR2, can promote the survival of stroke-generated hippocampal and striatal neurons.


Subject(s)
Antibodies/administration & dosage , Brain/drug effects , Infarction, Middle Cerebral Artery/physiopathology , Neurons/drug effects , Stem Cells/drug effects , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Animals , Brain/cytology , Brain/pathology , Cell Survival/drug effects , Injections, Intraventricular , Male , Nerve Regeneration/drug effects , Nerve Regeneration/physiology , Neurons/cytology , Rats , Rats, Wistar , Stem Cells/cytology , Tumor Necrosis Factor-alpha/immunology
4.
Stroke ; 36(8): 1790-5, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16002766

ABSTRACT

BACKGROUND AND PURPOSE: Stroke induced by middle cerebral artery occlusion (MCAO) triggers increased neurogenesis in the damaged striatum and nondamaged hippocampus of young adult rodents. We explored whether stroke influences neurogenesis similarly in the aged brain. METHODS: Young adult (3 months) and old (15 months) rats were subjected to 1 hour of MCAO, and new cells were labeled by intraperitoneal injection of 5-bromo-2'-deoxyuridine 5'-monophosphate (BrdU), a marker for dividing cells, for 2 weeks thereafter. Animals were euthanized at 7 weeks after the insult, and neurogenesis was assessed immunocytochemically with antibodies against BrdU and neuronal markers with epifluorescence or confocal microscopy. RESULTS: Young and old rats exhibited the same increased numbers of new striatal neurons after stroke, despite basal cell proliferation in the subventricular zone being reduced in the aged brain. In contrast, both the number of stroke-generated granule cells and basal neurogenesis in the dentate subgranular zone were lower in old compared with young animals. Also, the ability of newly formed cells to differentiate into neurons was impaired in the aged dentate gyrus. CONCLUSIONS: Basal neurogenesis is impaired in the subgranular and subventricular zones of aged animals, but both regions react to stroke with increased formation of new neurons. The magnitude of striatal neurogenesis after stroke is similar in young and old animals, indicating that this potential mechanism for self-repair also operates in the aged brain.


Subject(s)
Aging , Brain/pathology , Stroke/pathology , Animals , Brain/metabolism , Bromodeoxyuridine/pharmacology , Cell Count , Cell Differentiation , Cell Proliferation , Cerebral Arteries/pathology , Dentate Gyrus/pathology , Female , Hippocampus/metabolism , Immunohistochemistry , Infarction, Middle Cerebral Artery , Injections, Intraperitoneal , Ischemia/pathology , Ki-67 Antigen/biosynthesis , Microscopy, Confocal , Microscopy, Fluorescence , Neurons/metabolism , Rats , Rats, Wistar , Stem Cells/cytology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...